Barrow, Hanley, Mewhinney & Strauss
PBH icon

Barrow, Hanley, Mewhinney & Strauss’s Prestige Consumer Healthcare PBH Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30K Hold
634
– – ﹤0.01% 173
2026
Q1 		$37.6K Buy
634
+41
+7% +$2.66K ﹤0.01% 165
2025
Q4 		$36.6K Buy
593
+45
+8% +$2.75K ﹤0.01% 159
2025
Q3 		$34.2K Buy
548
+283
+107% +$19.7K ﹤0.01% 159
2025
Q2 		$21.2K Hold
265
– – ﹤0.01% 157
2025
Q1 		$22.8K Sell
265
-30
-10% -$2.46K ﹤0.01% 159
2024
Q4 		$23K Hold
295
– – ﹤0.01% 162
2024
Q3 		$21.3K Buy
+295
New +$20.9K ﹤0.01% 166

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's PBH Position: Q2 2026 in Review

Barrow, Hanley, Mewhinney & Strauss held its Prestige Consumer Healthcare (PBH) position steady in Q2 2026 at 634 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Barrow, Hanley, Mewhinney & Strauss first reported a position in PBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $37.6K in Q1 2026. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 634 shares of Prestige Consumer Healthcare worth $30K as of Q2 2026.
  • Barrow, Hanley, Mewhinney & Strauss left its Prestige Consumer Healthcare share count unchanged in Q2 2026.
  • Prestige Consumer Healthcare made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q2 2026, its #173 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Prestige Consumer Healthcare in Q3 2024 and has held it in 8 quarters since.
  • Barrow, Hanley, Mewhinney & Strauss's Prestige Consumer Healthcare position peaked at $37.6K in Q1 2026.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2026, filed 12 Aug 2026.